Global Market Research Report on Respiratory Syncytial Virus (RSV) Diagnostic Market 2016 is a professional and in-depth complete study on the current state of the Respiratory Syncytial Virus (RSV) Diagnostic worldwide.

Deerfield Beach, FL -- (SBWire) -- 07/14/2017 --New report on Respiratory Syncytial Virus (RSV) is a virus which causes respiratory infections such as bronchiolitis and pneumonia. Globally, the cases of RSV infections are on the rise which is fueling the demand for rapid diagnostic techniques. According to the CDC, each year, on an average, RSV leads to the hospitalization of around 1,32,000- 172,000 children below the age of five and the death of around 14,000 adults above the age of 65, in the United States alone. This rising incidence of RSV infections is the major driving force for this market. As the clinical symptoms of RSV infections are indistinguishable from other respiratory infections, there is a growing need for rapid, specific and sensitive diagnostic techniques. The current shortage of specific treatment options and the development of vaccines for RSV in the future are the major restraints for this market. Around 99% of RSV associated deaths of children below the age of five are from developing countries, which would lead to an increased demand for diagnostic methods in these countries.

Get Free Sample Report Of Respiratory Syncytial Virus (RSV) Diagnostic Market @ http://www.marketresearchstore.com/report/world-respiratory-syncytial-virus-diagnostic-market-68383#RequestSample

The RSV Diagnostic Market by Technology The RSV Diagnostic Market is segmented based on technologies such as Molecular Diagnostics, Immunoassays, Monoclonal Antibodies, Differential Light Scattering, Flow Cytometry, Artificial Intelligence, Chromatography, Diagnostic Imaging, Liposomes, Gel Microdroplets, and Others. Among these segments, Molecular Diagnostics have a higher sensitivity and specificity. The RSV Diagnostic Market by End Users: The major consumers for diagnostic kits include Hospitals, Nursing homes, Commercial Laboratories, and Public Health Laboratories. Hospitals are the major end user for RSV Diagnostic market. In the year 2000, 402,000 emergency room visits, 2,36,000 hospital outpatient visits and 86,000 hospitalizations of children below the age of five years were a result of RSV infection The RSV Diagnostic Market by Geographic Distribution The RSV diagnostic market involves North America, Europe, Asia Pacific and Rest of the World. Currently, the market is dominated by North America and Europe due to the increasing cases of respiratory diseases. However, Asia-Pacific region is an emerging market, as there are increasing incidences of RSV infections and a growing healthcare awareness.

Do Inquiry To Buy Report Of Respiratory Syncytial Virus (RSV) Diagnostic Market @ http://www.marketresearchstore.com/report/world-respiratory-syncytial-virus-diagnostic-market-68383#InquiryForBuying

RSV Diagnostic Market by Technology

Molecular Diagnostics
Monoclonal Antibodies
Immunoassays
Differential Light Scattering
Artificial Intelligence
Liposomes
Flow Cytometry
Chromatography
Diagnostic Imaging
Gel Microdroplets

RSV Diagnostic Market by End Users

Hospitals
Nursing homes
Commercial Laboratories
Public Health Laboratories

The RSV Diagnostic Market by Geographic Distribution

North America
Europe
Asia Pacific
Rest of the World